Linde PLC

Company facts

Industry

Industrial Inorganic Chemicals

Headquarters

Woking Surrey

Most recent report

10-Q, filed Jul 31, 2026

Filings on record

753 filings

On EDGAR

CIK 1707925

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 3 of 16 sections worth reading, with 1 positive, 7 notable, and 1 negative flags.

• INDEX TO NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

  Detailed financials with strong growth and substantial Russia litigation exposures.
  Notable

  • Issued €1.6B of Euro-denominated notes in May 2026 (floating-rate, 3.200%, 3.800%).
  Negative

  • Combined $1.8B Russia contingent liabilities (RCA $1.1B, Amur GPP $0.7B) plus €0.8B bank claims.

• Item 2

  Real results: sales up 9%, EPS up 11%, plus segment trends and capex detail.
  Positive

  • Sales up 9% and EPS up 11% in Q2 2026 vs Q2 2025, a strong quarter.
  Notable

  • EMEA volumes fell 1% in Q2 and 2% in H1 2026, led by manufacturing end-market weakness.
  • APAC volumes up 6% in Q2 and H1 2026, driven by new project start-ups and equipment sales.
  • H1 2026 capex of $2,780M was $253M higher than prior year, for backlog growth.
  • Sale-of-gas backlog of large projects under construction is $8.1B at June 30, 2026.
  • New Form S-3 filed May 5, 2026; European debt program increased to €25.0B from €20.0B.

• Unregistered Sales and Repurchases (Item 2)

  Buyback pace and remaining authorization are key cash-return metrics for Linde.
  Notable

  • Remaining buyback authorization decreased to $5.6 billion from $6.5 billion at the end of Q1 2026.

What changed: Jun 2026 vs. Mar 2026

About 8% of LIN's Jun 2026 10-Q is new information. 22 paragraphs were added, 122 changed, and 38 removed. Below are the most important lines SECSift identified.

• Item 2 62
• INDEX TO NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 39
• Item 6 1